553 related articles for article (PubMed ID: 32041627)
1. Menopausal symptoms in relationship to breast cancer-specific quality of life after adjuvant cytotoxic treatment in young breast cancer survivors.
Yeo W; Pang E; Liem GS; Suen JJS; Ng RYW; Yip CCH; Li L; Yip CHW; Mo FKF
Health Qual Life Outcomes; 2020 Feb; 18(1):24. PubMed ID: 32041627
[TBL] [Abstract][Full Text] [Related]
2. Profiles of lipids, blood pressure and weight changes among premenopausal Chinese breast cancer patients after adjuvant chemotherapy.
Yeo W; Mo FKF; Pang E; Suen JJS; Koh J; Loong HHF; Yip CCH; Ng RYW; Yip CHW; Tang NLS; Liem GS
BMC Womens Health; 2017 Jul; 17(1):55. PubMed ID: 28750616
[TBL] [Abstract][Full Text] [Related]
3. Quality of life of young Chinese breast cancer patients after adjuvant chemotherapy.
Yeo W; Mo FK; Pang E; Suen JJ; Koh J; Yip CH; Yip CC; Li L; Loong HH; Liem GS
Cancer Manag Res; 2018; 10():383-389. PubMed ID: 29503585
[TBL] [Abstract][Full Text] [Related]
4. How does adjuvant chemotherapy affect menopausal symptoms, sexual function, and quality of life after breast cancer?
Marino JL; Saunders CM; Emery LI; Green H; Doherty DA; Hickey M
Menopause; 2016 Sep; 23(9):1000-8. PubMed ID: 27272225
[TBL] [Abstract][Full Text] [Related]
5. Menopausal symptoms in breast cancer survivors nearly 6 years after diagnosis.
Davis SR; Panjari M; Robinson PJ; Fradkin P; Bell RJ
Menopause; 2014 Oct; 21(10):1075-81. PubMed ID: 24618765
[TBL] [Abstract][Full Text] [Related]
6. Partner status moderates the relationships between sexual problems and self-efficacy for managing sexual problems and psychosocial quality-of-life for postmenopausal breast cancer survivors taking adjuvant endocrine therapy.
Dorfman CS; Arthur SS; Kimmick GG; Westbrook KW; Marcom PK; Corbett C; Edmond SN; Shelby RA
Menopause; 2019 Aug; 26(8):823-832. PubMed ID: 30994574
[TBL] [Abstract][Full Text] [Related]
7. How Menopause Symptoms and Attitude Impact Korean Women's Quality of Life After Adjuvant Treatment for Breast Cancer.
Gang M; Jung MS; Park S; Park Y; Oh K
Cancer Nurs; 2017; 40(6):E60-E66. PubMed ID: 27922913
[TBL] [Abstract][Full Text] [Related]
8. Chemotherapy-induced amenorrhea, menopause-specific quality of life, and endocrine profiles in premenopausal women with breast cancer who received adjuvant anthracycline-based chemotherapy: a prospective cohort study.
Yoo C; Yun MR; Ahn JH; Jung KH; Kim HJ; Kim JE; Park JY; Park KO; Yoon DH; Kim SB
Cancer Chemother Pharmacol; 2013 Sep; 72(3):565-75. PubMed ID: 23842722
[TBL] [Abstract][Full Text] [Related]
9. Chemotherapy-Related Amenorrhea and Menopause in Young Chinese Breast Cancer Patients: Analysis on Incidence, Risk Factors and Serum Hormone Profiles.
Liem GS; Mo FK; Pang E; Suen JJ; Tang NL; Lee KM; Yip CH; Tam WH; Ng R; Koh J; Yip CC; Kong GW; Yeo W
PLoS One; 2015; 10(10):e0140842. PubMed ID: 26485568
[TBL] [Abstract][Full Text] [Related]
10. Breast cancer: relationship between menopausal symptoms, physiologic health effects of cancer treatment and physical constraints on quality of life in long-term survivors.
Schultz PN; Klein MJ; Beck ML; Stava C; Sellin RV
J Clin Nurs; 2005 Feb; 14(2):204-11. PubMed ID: 15669929
[TBL] [Abstract][Full Text] [Related]
11. Obesity associates with vasomotor symptoms in postmenopause but with physical symptoms in perimenopause: a cross-sectional study.
Koo S; Ahn Y; Lim JY; Cho J; Park HY
BMC Womens Health; 2017 Dec; 17(1):126. PubMed ID: 29216853
[TBL] [Abstract][Full Text] [Related]
12. Quality of Life in a Randomized Breast Cancer Prevention Trial of Low-Dose Tamoxifen and Fenretinide in Premenopausal Women.
Serrano D; Gandini S; Guerrieri-Gonzaga A; Feroce I; Johansson H; Macis D; Aristarco V; Bonanni B; DeCensi A
Cancer Prev Res (Phila); 2018 Dec; 11(12):811-818. PubMed ID: 30352838
[TBL] [Abstract][Full Text] [Related]
13. Psychometric properties of the Chinese version of the Menopause-Specific Quality-of-Life questionnaire.
Nie G; Yang H; Liu J; Zhao C; Wang X
Menopause; 2017 May; 24(5):546-554. PubMed ID: 27922934
[TBL] [Abstract][Full Text] [Related]
14. Comparison of quality of life between 2-year and 3-or-more-year administration of leuprorelin acetate every-3-months depot in combination with tamoxifen as adjuvant endocrine treatment in premenopausal patients with endocrine-responsive breast cancer: a randomized controlled trial.
Ohashi Y; Shiba E; Yamashita H; Kurebayashi J; Noguchi S; Iwase H; Yoshida M; Fujimoto T
Support Care Cancer; 2018 Mar; 26(3):933-945. PubMed ID: 29063390
[TBL] [Abstract][Full Text] [Related]
15. Differential impact of endocrine therapy and chemotherapy on quality of life of breast cancer survivors: a prospective patient-reported outcomes analysis.
Ferreira AR; Di Meglio A; Pistilli B; Gbenou AS; El-Mouhebb M; Dauchy S; Charles C; Joly F; Everhard S; Lambertini M; Coutant C; Cottu P; Lerebours F; Petit T; Dalenc F; Rouanet P; Arnaud A; Martin A; Berille J; Ganz PA; Partridge AH; Delaloge S; Michiels S; Andre F; Vaz-Luis I
Ann Oncol; 2019 Nov; 30(11):1784-1795. PubMed ID: 31591636
[TBL] [Abstract][Full Text] [Related]
16. Sexual health in long-term breast cancer survivors.
Soldera SV; Ennis M; Lohmann AE; Goodwin PJ
Breast Cancer Res Treat; 2018 Nov; 172(1):159-166. PubMed ID: 30027300
[TBL] [Abstract][Full Text] [Related]
17. Psychometric properties of the Menopause Specific Quality of Life questionnaire among Thai women with a history of breast cancer.
Phligbua W; Smith EML; Barton DL
Eur J Oncol Nurs; 2018 Oct; 36():75-81. PubMed ID: 30322513
[TBL] [Abstract][Full Text] [Related]
18. Health-related quality of life of postmenopausal Chinese women with hormone receptor-positive early breast cancer during treatment with adjuvant aromatase inhibitors: a prospective, multicenter, non-interventional study.
Cao A; Zhang J; Liu X; Wu W; Liu Y; Fan Z; Zhang A; Zhou T; Fu P; Wang S; Ouyang Q; Tang J; Jiang H; Zhang X; Pang D; He J; Shi L; Wang X; Sheng Y; Mao D; Shao Z
Health Qual Life Outcomes; 2016 Mar; 14():51. PubMed ID: 27009092
[TBL] [Abstract][Full Text] [Related]
19. Amenorrhea in premenopausal women on the doxorubicin-and-cyclophosphamide-followed-by-docetaxel arm of NSABP B-30 trial.
Swain SM; Land SR; Ritter MW; Costantino JP; Cecchini RS; Mamounas EP; Wolmark N; Ganz PA
Breast Cancer Res Treat; 2009 Jan; 113(2):315-20. PubMed ID: 18302020
[TBL] [Abstract][Full Text] [Related]
20. Assessment of quality of life (QoL) in breast cancer patients by using EORTC QLQ-C30 and BR-23 questionnaires: A tertiary care center survey in the western region of Saudi Arabia.
Imran M; Al-Wassia R; Alkhayyat SS; Baig M; Al-Saati BA
PLoS One; 2019; 14(7):e0219093. PubMed ID: 31291302
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
